Article Details

FDA Cites Safety Concerns Over Pfizer and Lilly's Osteoarthritis Drug Tanezumab

Retrieved on: 2021-03-22 18:22:30

Tags for this article:

Click the tags to see associated articles and topics

FDA Cites Safety Concerns Over Pfizer and Lilly's Osteoarthritis Drug Tanezumab. View article details on hiswai:

Excerpt

The primary safety concern associated with the drug is rapidly progressing osteoarthritis (RPOA), which both Pfizer and Eli Lilly have observed in their ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo